EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Pathway‐specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease

Carolina Valentim, Jannis Denecke, Simon Frerich, Tobey J Betthauser, Yuanxi Li, Reihaneh Ahmadi, Nicolai Franzmeier, Alzheimer's Disease Neuroimaging Initiative (ADNI), Rainer Malik, Michael Ewers iD

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71939 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Alzheimer's & Dementia, online erschienen am 27.10.2026. Verfasst von Carolina Valentim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University, Munich, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Genetic Risk Score, tau Proteins. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon, Bundesministerium für Bildung und Forschung, Bundesministerium für Gesundheit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Genome‐wide association studies (GWASs) identified multiple genetic variants associated with Alzheimer's disease (AD) risk, yet the biological pathways linking these to amyloid and tau pathology remain unclear. METHODS We conducted a meta‐analysis of recent GWASs to identify independent genome‐wide significant single nucleotide polymorphisms which were mapped via gene‐set enrichment to derive pathway‐specific polygenic risk scores (pPRSs). Analyses included 441 amyloid‐positive participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI; 224 with longitudinal tau positron emission tomography [PET]) and 250 amyloid‐positive participants from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study (113 with longitudinal tau PET). Robust linear regressions tested cross‐sectional and longitudinal pPRS‐by‐amyloid chronicity interactions on tau PET. RESULTS Four pPRSs were identified including adaptive immune response, leukocyte activation, transport, and intracellular signaling. Only the transport pPRS strengthened amyloid–tau coupling cross‐sectionally across all Braak stages in ADNI ( p < 0.05) and at Braak I in A4 ( p < 0.05), with stronger effects observed in females; in ADNI, these associations persisted longitudinally only at the higher Braak stages. DISCUSSION Genetic variation in transport pathways modulates amyloid‐driven tau accumulation, revealing mechanisms shaping AD progression, beyond apolipoprotein E.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesGenetic Risk Scoretau ProteinsAgedAged, 80 and overFemaleHumansMaleBrainCross-Sectional StudiesGenetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotidePositron-Emission Tomography

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid chronicitypathway analysispolygenic risk scorepositron emission tomography imaging

Substanzen

Amyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University, Munich, Germany.
  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal and Gothenburg, Sweden.
  • German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

ORCID-Profile: Michael Ewers

Förderung

  • European Union's Horizon
  • Bundesministerium für Bildung und Forschung
  • Bundesministerium für Gesundheit
  • Deutsche Forschungsgesellschaft
  • Alzheimer's Association
  • Joachim Herz Foundation
  • Joachim Herz Stiftung

Zitieren

APA

Valentim, C., Denecke, J., Frerich, S., Betthauser, T. J., Li, Y., Ahmadi, R., Franzmeier, N., Alzheimer's Disease Neuroimaging Initiative (ADNI), Malik, R., & Ewers, M. (2026). Pathway‐specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71939

Vancouver

Valentim C, Denecke J, Frerich S, Betthauser TJ, Li Y, Ahmadi R, et al. Pathway‐specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71939

BibTeX
@article{Valentim2026,
  author = {Valentim, Carolina and Denecke, Jannis and Frerich, Simon and Betthauser, Tobey J and Li, Yuanxi and Ahmadi, Reihaneh and Franzmeier, Nicolai and Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimer's Disease Neuroimaging Initiative (ADNI) and Malik, Rainer and Ewers, Michael},
  title = {Pathway‐specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71939}
}
Kostenlos starten →